B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

FER

MOLECULAR TARGET

FER tyrosine kinase

UniProt: P16591NCBI Gene: 224145 compounds

FER (FER tyrosine kinase) is targeted by 45 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting FER

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1ibrutinib4.86128
2foretinib4.3476
3tozasertib4.3375
4ceritinib4.1965
5bosutinib4.0858
6doramapimod4.0657
7midostaurin3.8546
8brigatinib3.8144
9pazopanib3.6939
10neratinib3.6638
11nintedanib3.6136
12pelitinib3.5032
13tae 6843.4330
14fedratinib3.4029
15gilteritinib3.4029
16mln 80543.3327
17alectinib3.1823
18rociletinib3.1823
19at 92833.0921
20lestaurtinib3.0420
21pacritinib3.0420
22pf 037583093.0019
23danusertib2.9418
24r 4062.8316
25k 252a2.8316
26pf 005622712.7715
27apitolisib2.7114
28kw 24492.6413
29ast 4872.5612
30zotiraciclib2.5612
31raf 2652.4811
32defactinib2.4811
33mk 51082.4811
34lorlatinib2.4811
35azd 77622.309
36bms 7548072.309
37azd 14802.309
38su 0148132.208
39rebastinib2.208
40asp 30262.087
41cep 324961.956
42pf 038147351.795
43ucn 011.795
44Crizotinib0.691
45sp6001250.691

About FER as a Drug Target

FER (FER tyrosine kinase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 45 compounds with documented FER interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

FER inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.